Institute of Cardiovascular Sciences We are leaders in cardiovascular research, including atrial fibrillation and heart failure, thrombosis and haemostasis, and vascular biology.
News Launch of the national Congenital Heart Disease Priority Setting Partnership Today, 29 June 2021, sees the launch of the UK’s first national study to identify research priorities for children and adults diagnosed with congenital heart disease (CHD).
News New research award to investigate and treat thrombo-inflammation in diseases where red blood cell destruction occurs
Posted 13 July 2021 Partnership will create the next generation of researchers to transform global healthcare The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
Posted 29 June 2021 Launch of the national Congenital Heart Disease Priority Setting Partnership Today, 29 June 2021, sees the launch of the UK's first national study to identify research priorities for children and adults diagnosed with congenital heart disease (CHD).
Posted 15 June 2021 Professor's success story used to mark BHF's 60th birthday celebrations Professor Paulus Kirchhof's success story of the the EAST-AFNET 4 clinical trial has been featured in the BHF's 60th birthday celebrations.
Posted 06 May 2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb The University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.